Pubblicazioni Scientifiche
Dermatologia30 gen 2020
The prognostic value of tumor mitotic rate in children and adolescents with cutaneous melanoma
A retrospective cohort study
21 gen 2020
High Levels of Platelet-Lymphocyte Complexes in Patients with Psoriasis Are Associated with a Better Response to Anti–TNF-α Therapy
Psoriasis is currently considered to be an immune-mediated disease whose patho-mechanisms involve platelet activation, which seems to correlate with the activity of the disease.
21 gen 2020
Long-term use of fumaric acid esters for the treatment of psoriasis in daily practice
Fumaric acid ester (FAE) is the most commonly prescribed first-line systemic therapy for the treatment of psoriasis in Germany.
21 gen 2020
Pain, Anxiety, Depression, and Quality of Life in Patients with Vulvodynia
The term vulvodynia refers to vulvar pain of unknown origin lasting at least 3 months.
15 gen 2020
The Identification of Potential Therapeutic Targets for Cutaneous Squamous Cell Carcinoma
We performed a small interfering RNA screen to identify targets for cutaneous squamous cell carcinoma (cSCC) therapy in the ubiquitin/ubiquitin-like system.
15 gen 2020
Persistence of inflammatory phenotype in residual psoriatic plaques in patients on effective biologic therapy
Residual Psoriatic Plaques After Treatment
15 gen 2020
A systematic review of treatment strategies for erythrodermic psoriasis
Erythrodermic psoriasis (EP) is a severe, rare form of psoriasis that can be life threatening. Treatment of EP is usually based on anecdotal evidence or past clinical experience, which is in part due to the rarity and often emergent nature of this psoriasis subtype.
07 gen 2020
Comparing psoriasis advertisement methods with patient willingness to initiate treatment
Many patients with psoriasis struggle with taking biologic agents. The way in which providers present medications could enhance treatment adherence.
07 gen 2020
Development and preliminary validation of the Adolescent Psoriasis Quality of Life instrument (APso‐QOL)
a disease‐specific measure of quality of life in adolescents with psoriasis
07 gen 2020
Topical tacrolimus in adult atopic dermatitis: a consensus based on a 15-year experience
Atopic dermatitis (AD) is one of the most common cutaneous inflammatory diseases both in adults and in children.
17 dic 2019
Sex-stratified polygenic risk score identifies individuals at increased risk of basal cell carcinoma
The incidence of basal cell carcinoma (BCC) is higher among men than women.
17 dic 2019
Associations of eczema phenotypes with emotional and behavioural problems from birth until school age
The Generation R Study
17 dic 2019
Molecular genetics of cutaneous squamous cell carcinoma: perspective for treatment strategies
Cutaneous squamous cell carcinoma (cSCC) represents 20% of all skin cancers.
09 dic 2019
Predictors of hospital readmission in US adults with psoriasis
Readmission in Psoriasis
09 dic 2019
Five-point checklist for skin cancer detection in primary care
Skin cancer screening interventions often relay on the involvement of general practitioners (GPs).
09 dic 2019
Association of Bariatric Surgery With Skin Cancer Incidence in Adults With Obesity
A Nonrandomized Controlled Trial
02 dic 2019
Diagnosis and management of vulvar cancer: A review
Vulvar malignancies represent a serious gynecologic health concern, especially given the increasing incidence over the past several decades.
02 dic 2019
From bench to bedside: evolving therapeutic targets in autoimmune blistering disease
Autoimmune blistering diseases comprise a group of heterogenous conditions characterized by the loss of tolerance and subsequent development of autoantibodies targeting epidermal and subepidermal adhesion proteins.
02 dic 2019
European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 1: treatment delivery and established indications - actinic keratoses,
Topical photodynamic therapy (PDT) is a widely approved therapy for actinic keratoses, Bowen's disease (squamous cell carcinoma in situ), superficial and certain thin basal cell carcinomas.
26 nov 2019
Abolizione del superticket, sarà a carico dello Stato da luglio 2020
La progressiva abolizione entrerà nella Legge di Bilancio. L'addio al balzello inizialmente dovrebbe valere la metà, quindi circa 385 milioni di euro